The mRNA vaccine primes HPV16 E6–specific CD8+ T cells via APC presentation; these CTLs recognize E6 peptides on MHC I of infected epithelial cells and kill them via perforin/granzyme-mediated apoptosis (with CD4+ T-cell help).